Dimensional Fund Advisors’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Dimensional Fund Advisors’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,210	Closed	-$44.6K	–	3422
2024 Q1	$44.6K	Buy	+12,210	New	+$46.8K	﹤0.01%	3338
2023 Q4	–	Sell	-19,505	Closed	-$41.9K	–	3465
2023 Q3	$41.9K	Sell	19,505 -3,239	-14%	-$12.9K	﹤0.01%	3392
2023 Q2	$127K	Buy	22,744 +3,618	+19%	+$28.3K	﹤0.01%	3298
2023 Q1	$115K	Hold	19,126	–	–	﹤0.01%	3285
2022 Q4	$109	Buy	+19,126	New	+$107K	﹤0.01%	3315

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Dimensional Fund Advisors's OMGA Position: Q2 2024 in Review

Dimensional Fund Advisors sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q2 2024, closing a stake of 12,210 shares — an estimated $44.6K sold.

Dimensional Fund Advisors first reported a position in OMGA in Q4 2022 and held it in 5 quarters. The position peaked at $127K in Q2 2023. 68 funds tracked by Wall St. Rank hold OMGA as of Q2 2024.

Dimensional Fund Advisors reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Dimensional Fund Advisors sold 12,210 Omega Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $44.6K.
Dimensional Fund Advisors first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
Dimensional Fund Advisors's Omega Therapeutics, Inc. Common Stock position peaked at $127K in Q2 2023.
68 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.